From model complexes to metalloprotein inhibition: A synergistic approach to structure-based drug discovery

David T. Puerta, Julie R. Schames, Richard H. Henchman, J. Andrew McCammon, Seth M. Cohen

    Research output: Contribution to journalArticlepeer-review

    Abstract

    A happy marriage: The combination of synthetic model chemistry with computational conformational analysis has revealed the binding of an inhibitor to a medically important metalloenzyme. [(TpPh,Me)Zn(mbt)] (Tp Ph,Me = hydrotris (3,5-phenylmethylpyrazolyl)borate, mbt = 2-methoxybenzenethiol) was used to template the conformation of a known inhibitor in the active site of the metalloenzyme, as shown by the green ligand inside the active site of the protein (the Zn11 ion is shown in purple).
    Original languageEnglish
    Pages (from-to)3772-3774
    Number of pages2
    JournalAngewandte Chemie - International Edition
    Volume42
    Issue number32
    DOIs
    Publication statusPublished - 18 Aug 2003

    Keywords

    • Bioinorganic chemistry
    • Computer chemistry
    • Drug design
    • Metalloproteins
    • Zinc

    Fingerprint

    Dive into the research topics of 'From model complexes to metalloprotein inhibition: A synergistic approach to structure-based drug discovery'. Together they form a unique fingerprint.

    Cite this